OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review
Lingli Xie, Wenfang Xia
Life Sciences (2022) Vol. 300, pp. 120543-120543
Closed Access | Times Cited: 23
Lingli Xie, Wenfang Xia
Life Sciences (2022) Vol. 300, pp. 120543-120543
Closed Access | Times Cited: 23
Showing 23 citing articles:
Insulin resistance and cardiovascular disease
Constantine E. Kosmas, Maria D. Bousvarou, Christina Kostara, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 3
Open Access | Times Cited: 133
Constantine E. Kosmas, Maria D. Bousvarou, Christina Kostara, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 3
Open Access | Times Cited: 133
Chemical synthesis of oligosaccharides and their application in new drug research
Zhimin Lv, Hongyu Liu, Huifang Hao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115164-115164
Open Access | Times Cited: 24
Zhimin Lv, Hongyu Liu, Huifang Hao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115164-115164
Open Access | Times Cited: 24
A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand
Natthakan Chitpim, Pattara Leelahavarong, Juthamas Prawjaeng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Natthakan Chitpim, Pattara Leelahavarong, Juthamas Prawjaeng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Stigma and petals of Crocus sativus L.: Review and comparison of phytochemistry and pharmacology
Xue Li, Jin Xie, Hong Jin Fan, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 8, pp. 104918-104918
Open Access | Times Cited: 12
Xue Li, Jin Xie, Hong Jin Fan, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 8, pp. 104918-104918
Open Access | Times Cited: 12
Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
Neda Shakour, Shima Karami, Mehrdad Iranshahi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102934-102934
Closed Access | Times Cited: 12
Neda Shakour, Shima Karami, Mehrdad Iranshahi, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102934-102934
Closed Access | Times Cited: 12
Exploring novel lead scaffolds for SGLT2 inhibitors: Insights from machine learning and molecular dynamics simulations
Yuandong Yu, Yuting Xia, Guizhao Liang
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130375-130375
Closed Access | Times Cited: 4
Yuandong Yu, Yuting Xia, Guizhao Liang
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130375-130375
Closed Access | Times Cited: 4
Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
Mahdieh Anoush, Neda Taghaddosi, Zahra Bokaei Hosseini, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 163-170
Open Access
Mahdieh Anoush, Neda Taghaddosi, Zahra Bokaei Hosseini, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 163-170
Open Access
Effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors, dapagliflozin and canagliflozin, on the musculoskeletal system in an experimental model of diabetes induced by high-fat diet and streptozotocin in rats
Piotr Londzin, Maria Zych, Aleksandra Janas, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117912-117912
Open Access
Piotr Londzin, Maria Zych, Aleksandra Janas, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117912-117912
Open Access
Metabolic crosstalk and therapeutic interplay between diabetes and hyperuricemia
Tianshu Yang, Lingyun Luo, Xuelian Luo, et al.
Diabetes Research and Clinical Practice (2025) Vol. 224, pp. 112204-112204
Open Access
Tianshu Yang, Lingyun Luo, Xuelian Luo, et al.
Diabetes Research and Clinical Practice (2025) Vol. 224, pp. 112204-112204
Open Access
Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes
Nazif Yalçın, Selman Aktaş, Seyit Uyar, et al.
Life (2025) Vol. 15, Iss. 5, pp. 722-722
Open Access
Nazif Yalçın, Selman Aktaş, Seyit Uyar, et al.
Life (2025) Vol. 15, Iss. 5, pp. 722-722
Open Access
The improvement effect of ellagic acid and urolithins on metabolic diseases: Pharmacology and mechanism
Ying-Hao Wang, Wei Peng, Chunfeng Li, et al.
Food & medicine homology. (2024)
Closed Access | Times Cited: 2
Ying-Hao Wang, Wei Peng, Chunfeng Li, et al.
Food & medicine homology. (2024)
Closed Access | Times Cited: 2
The Effects of SGLT2 Inhibitors on Blood Pressure and Other Cardiometabolic Risk Factors
Alexandra Katsimardou, Panagiotis Theofilis, Aikaterini Vordoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12384-12384
Open Access | Times Cited: 2
Alexandra Katsimardou, Panagiotis Theofilis, Aikaterini Vordoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12384-12384
Open Access | Times Cited: 2
Genetic Variation in Targets of Antidiabetic Drugs and Amyotrophic Lateral Sclerosis Risk
Mengxia Wan, Linjing Zhang, Junyan Huo, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2733-2733
Open Access | Times Cited: 2
Mengxia Wan, Linjing Zhang, Junyan Huo, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2733-2733
Open Access | Times Cited: 2
SGLT2 Inhibitors and Their Effect on Urolithiasis: Current Evidence and Future Directions
Živka Dika, Marijana Živko, Marina Kljajić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 6017-6017
Open Access | Times Cited: 1
Živka Dika, Marijana Živko, Marina Kljajić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 6017-6017
Open Access | Times Cited: 1
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Acute Coronary Syndrome
Jiawei Song, Yan Liu, Yani Xu, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1847-1855
Open Access | Times Cited: 1
Jiawei Song, Yan Liu, Yani Xu, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1847-1855
Open Access | Times Cited: 1
SGLT2 Inhibitors and Uric Acid Homeostasis
Ava M. Zapf, Owen M. Woodward
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 2, pp. 157-172
Open Access | Times Cited: 1
Ava M. Zapf, Owen M. Woodward
Gout Urate and Crystal Deposition Disease (2024) Vol. 2, Iss. 2, pp. 157-172
Open Access | Times Cited: 1
Betahistine prevents development of endolymphatic hydrops in a mouse model of insulin resistance and diabetes
Ann-Ki Pålbrink, René in ‘t Zandt, Måns Magnusson, et al.
Acta Oto-Laryngologica (2023) Vol. 143, Iss. 2, pp. 127-133
Open Access | Times Cited: 3
Ann-Ki Pålbrink, René in ‘t Zandt, Måns Magnusson, et al.
Acta Oto-Laryngologica (2023) Vol. 143, Iss. 2, pp. 127-133
Open Access | Times Cited: 3
Research Progress of Sodium-Glucose Cotransporter 2 Inhibitor in the Treatment of Polycystic Ovary Syndrome
玺印 岳
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 4573-4580
Closed Access
玺印 岳
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 4573-4580
Closed Access
Empagliflozin Effect on Left Cardiac Parameters in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ghaith Eljadid, Mohamed Saad Rakab, Ahmed M. Mansour, et al.
Cureus (2024)
Open Access
Ghaith Eljadid, Mohamed Saad Rakab, Ahmed M. Mansour, et al.
Cureus (2024)
Open Access
Medicinal and Nutritional Importance of Crocus sativus L. in Human Health
Saima Shakil Malik, Nazish Akhtar, Mo Shadab, et al.
(2024), pp. 315-335
Closed Access
Saima Shakil Malik, Nazish Akhtar, Mo Shadab, et al.
(2024), pp. 315-335
Closed Access
Pathogenetic relationship of microbiome and metabolic disorders on the background of hypertension and gout: Potential targets of pharmacotherapy
Snezhana D Sinyushkina, A. V. Gorinova, A. S. Belousova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 16, pp. 292-301
Open Access
Snezhana D Sinyushkina, A. V. Gorinova, A. S. Belousova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 16, pp. 292-301
Open Access
An integrated approach for obesity management: the effectiveness of glucagon-like peptide 1 agonist and life-style interventions for obesity management
Andrii Dinets, Maksym Gorobeiko, V.V. Zdorna, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2022) Vol. 18, Iss. 3, pp. 145-152
Closed Access | Times Cited: 2
Andrii Dinets, Maksym Gorobeiko, V.V. Zdorna, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2022) Vol. 18, Iss. 3, pp. 145-152
Closed Access | Times Cited: 2
Sodium–Glucose Cotransporter-2 Inhibitors: An Old Medication With New Indication in Heart Failure With Preserved Ejection Fraction
Mohamed Toufic El Hussein, Cassandra Reeves
The Journal for Nurse Practitioners (2023) Vol. 19, Iss. 8, pp. 104716-104716
Closed Access
Mohamed Toufic El Hussein, Cassandra Reeves
The Journal for Nurse Practitioners (2023) Vol. 19, Iss. 8, pp. 104716-104716
Closed Access
